About Paviour
Paviour is a company based in Delhi (India) founded in 1998. The company has 57 employees. Paviour offers products and services including Specialty Pharmaceutical Products and Distribution Services.
- Headquarter Delhi, India
- Employees 57
- SectorsHealthcare
- Email••••••••
- Social X Facebook
- Legal Name Paviour Pharmaceuticals Pvt Ltd
- Date of Incorporation 01 Sep, 1998
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹87.47 Cr
FY 2025 · +14% YoY
- Net Profit₹1.46 Cr
FY 2025 · 2% margin
- EBITDA₹2.52 Cr
FY 2025 · 3% margin
- Employee Count57
Associated legal entities of Paviour
Paviour operates through Paviour Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Paviour Pharmaceuticals Private Limited CIN U24231DL1998PTC095875 | Active | 01 Sep 1998 | New Delhi, Delhi | ₹87.5 Cr | 57 | 2 | View details |
Products & Services of Paviour
Paviour offers a comprehensive portfolio of products and services, including Specialty Pharmaceutical Products and Distribution Services.
Importing and marketing of specialty drugs that are not produced locally
Distribution of pharmaceutical products through various channels
Board of directors of Paviour Pharmaceuticals Private Limited (Paviour)
Paviour Pharmaceuticals Private Limited is the primary company behind Paviour. The board of Paviour Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Anil Sawhney, appointed in 1998.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anil Sawhney DIN 01147115 | Director | 01 Sep 1998 | 28 yrs 1 mo | Paviour Pharmaceuticals Private Limited |
| Neeru Sawhney DIN 00273522 | Director | 01 Sep 1998 | 28 yrs 1 mo | Paviour Pharmaceuticals Private Limited |
Financials of Paviour
Figures of Paviour Pharmaceuticals Private Limited, the primary company behind Paviour, for FY 2025. Revenue was ₹87.47 Cr (+14% year on year). Net profit was ₹1.46 Cr (2% margin). EBITDA was ₹2.52 Cr (3% margin). Revenue has grown at a compounded annual rate of +15% over three years and +11% over five years.
- ₹87.47 CrRevenue · FY 2025 · +14% YoY
- ₹1.46 CrNet profit · 2% margin
- ₹2.52 CrEBITDA · 3% margin
- ₹62 LakhPaid-up capital
- 57Employees (provident fund records)
- +15%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Paviour Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Paviour
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Paviour
10 companies that operate in the same segment as Paviour (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Paviour
Paviour was founded in 1998.
Paviour is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Paviour has 57 employees.
The primary company behind Paviour, Paviour Pharmaceuticals Private Limited, reported revenue of ₹87.47 Cr for FY 2025, up 14% year on year.
Paviour Pharmaceuticals . Was Established In 1998 To Focus On The Importing, Marketing, And Distribution Of Pharmaceutical Specialty Products That Are Not Manufactured Locally. Marketing Agreements Have Been Formed With International Entities Such As Biotest Pharma From Germany And Chiesi Farmaceutici Spa From Italy, Enabling Access To Specialized Drugs. The Company Maintains Offices In Key Indian Cities Including New Delhi, Mumbai, Chennai, Raipur, And Kolkata To Facilitate Operations. Products In The Pipeline, Like Visudyne, Are Managed Through These Partnerships, Ensuring Availability Of Essential Pharmaceuticals. Adverse Event Reporting And Training Services Are Also Provided To Support Compliance And Quality Standards.
Paviour offers Specialty Pharmaceutical Products and Distribution Services.
Paviour operates through Paviour Pharmaceuticals Private Limited.
The legal entities of Paviour currently have 2 directors, including Anil Sawhney, Neeru Sawhney.